Roche’s Next Generation Roponin T Test Gets FDA Approval

The FDA has granted marketing approval to Roche’s Troponin T test as an aid in the diagnosis of myocardial infarction.

The device reports the troponin biomarker within nine minutes. — Cynthia Jessup